Axogen, Inc.

• Axogen, Inc. Estimates – BMV:AXGN
  TradingView · 23 Oct 2026
• Axogen Is Maintained at Overweight by Barclays
  Moomoo · 23 Oct 2026
• Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026
  GlobeNewswire · 14 Oct 2026
• Axogen to report Q3 2026 financial results on O...
  Pluang · 14 Oct 2026
• Axogen (NasdaqCM:AXGN) Stock Forecast & Analyst Predictions
  Simply Wall Street · 13 Oct 2026
• AxoGen stock initiated at Buy by BofA on growth outlook
  Investing.com · 12 Oct 2026
• Axogen (AXGN) Is Back In The Spotlight, What Has Investors Looking Closer?
  Simply Wall Street · 09 Oct 2026
• Foley Hoag Advises Axogen on $200M Acquisition of BioCircuit Technologies
  Foley Hoag · 02 Oct 2026
• Axogen Completes Acquisition of BioCircuit Technologies,
  GlobeNewswire · 01 Oct 2026
• Axogen completes acquisition of BioCircuit Technologies By Investing.com
  Investing.com UK · 01 Oct 2026
• Axogen Completes Acquisition of BioCircuit Technologies, Expanding Peripheral Nerve Repair Portfolio
  Quiver Quantitative · 01 Oct 2026
• Truist reiterates Buy on AxoGen stock after Aetna coverage win
  Investing.com · 29 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →